Clinical trials
Wounds and Injuries trials in Switzerland with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Zurich | 3 |
| University Children's Hospital, Zurich | 2 |
| 41Hemiverse AG | 1 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Australian and New Zealand Intensive Care Research Centre | 1 |
| ETH Zurich | 1 |
| Ilker Uckay | 1 |
| Luzerner Kantonsspital | 1 |
| Pediatric Clinical Research Platform | 1 |
| Rehaklinik Bellikon | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wounds and Injuries | 20 |
| Stress Disorders, Post-Traumatic | 4 |
| Anxiety Disorders | 2 |
| Arthritis, Psoriatic | 1 |
| Arthritis, Rheumatoid | 1 |
| Brain Injuries | 1 |
| Brain Injuries, Traumatic | 1 |
| Burns | 1 |
| Emergencies | 1 |
| Infections | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.